Applications Of Integrated Solutions In Accelerated Drug Development Programs
Summary: Driving more efficient timelines is key to bringing a product to market when you are on an accelerated track. Expedited program designations and approaches are available from FDA of which break though therapy designation is the latest. If you do not have the pharmaceutical, analytical, packaging and project management resources and infrastructure in-house, maintaining a development program at a rate that takes full advantage of the benefits of receiving an expedited designation from FDA may be challenging.
Watch the webinar and hear from industry experts on how an integrated development program approach can be used to mitigate risk and reduce timelines to get maximum benefit from receiving expedited or orphan designations for your drug.